The vast majority of insurance companies require patients with Crohn's disease and ulcerative colitis to fail conventional treatment with steroids and immunomodulators before starting biologic therapy ...
DelveInsight's Ulcerative Colitis Market Insights report includes a comprehensive understanding of current treatment practices, ulcerative colitis emerging drugs, market share of individual therapies, ...
Overall, the reviewers wrote, most IBD therapies “appear safe and effective when used in chronic kidney disease, including on ...
Tel Aviv, Israel, December 8th, 2025, FinanceWireRecognition by the European Crohn’s and Colitis Organisation marks a ...
Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — A presenter at the Crohn’s & Colitis Congress highlighted tips for successful decision-making with ...
Psychologist Melissa Hunt and gastroenterologist Chung Sang Tse and colleagues have found that cognitive behavioral therapy ...
Concomitant inflammatory bowel disease (IBD) negatively affects disease control and treatment response among patients with psoriatic arthritis (PsA) receiving biologic therapy, according to study ...
How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...
Many patients with inflammatory bowel disease (IBD) suffer from abdominal pain even between acute inflammatory flare-ups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback